An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
Denas
Gentian
G
Clinical Cardiology, Thrombosis Centre, Via Giustiniani 2, 35128 Padova, Italy.
Cucchini
Umberto
U
Iliceto
Sabino
S
Pengo
Vittorio
V
D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors*; D000933:Antifibrinolytic Agents / Q000008:administration & dosage*; D001777:Blood Coagulation / Q000187:drug effects*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D008875:Middle Aged; D011517:Prothrombin Time; D010837:Vitamin K 1 / Q000008:administration & dosage*; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D014859:Warfarin; D010837:Vitamin K 1